28/09/2021 (Agence Europe) – The European Medicines Agency (EMA) announced on Monday 27 September that it had started to review a request for the use of a third dose of the Covid-19 vaccine developed by Moderna. The EMA, which had begun evaluating the “data from the literature” available on the subject (see EUROPE B12785A18), will evaluate in particular the results of clinical trials currently being conducted by the company. However, it recalls that it is not convinced of the...